This systematic review analyzes dysrhythmias risk in patients with supratherapeutic loperamide exposure, suggesting the need for cardiac monitoring.
Patients presenting with supratherapeutic loperamide exposure appear to be at high risk for life-threatening dysrhythmias, and close cardiac monitoring should be broadly considered in this population. Management options include appropriate antiarrhythmic and cardiocirculatory support measures.
No takes yet. Share an insight, caveat, or question.
Bekka et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: